Lineage Cell Therapeutics Inc (LCTX)vsRevolution Medicines Inc (RVMD)
LCTX
Lineage Cell Therapeutics Inc
$0.98
-4.55%
HEALTHCARE · Cap: $248.63M
RVMD
Revolution Medicines Inc
$177.73
-11.04%
HEALTHCARE · Cap: $40.45B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage Cell Therapeutics Inc generates 1663% more annual revenue ($13.08M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -246.6%. RVMD earns a higher WallStSmart Score of 24/100 (F).
LCTX
Avoid18
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+84.0%
Fair Value
$11.28
Current Price
$0.98
$10.30 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Expensive relative to growth rate
Trading at 14.6x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : LCTX
The strongest argument for LCTX centers on Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : LCTX
The primary concerns for LCTX are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
LCTX profiles as a turnaround stock while RVMD is a value play — different risk/reward profiles.
LCTX carries more volatility with a beta of 1.69 — expect wider price swings.
LCTX is growing revenue faster at -61.3% — sustainability is the question.
LCTX generates stronger free cash flow (-7M), providing more financial flexibility.
Bottom Line
RVMD scores higher overall (24/100 vs 18/100). LCTX offers better value entry with a 84.0% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage Cell Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment of degenerative diseases in the United States and internationally. The company is headquartered in Carlsbad, California.
Visit Website →Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?